Literature DB >> 8067404

Brain edema resolution by CSF pathways and brain vasculature in cats.

A Marmarou1, G Hochwald, T Nakamura, K Tanaka, J Weaver, J Dunbar.   

Abstract

Brain edema is a major contributor to the brain swelling process and raised intracranial pressure, yet the specific pathways involved in clearance of brain edema (fluid and proteins) and their relative contribution to the resolution process remain unknown. The objective of this study was to document the temporal course of edema resolution from brain to cerebrospinal fluid (CSF) and by the brain vasculature. Radioiodinated (125I) cat serum albumin (RICSA) was infused continuously into the white matter of anesthetized adult cats for 8 h, and ventriculocisternal perfusion was used to monitor the RICSA activity in CSF at 15-min intervals and to compare with the blood taken at 15-min intervals. The RICSA that cleared from the brain in 8 h measured 29.8% of the amount infused. Of the amount of RICSA leaving the brain, we found that the CSF compartment accounted for 87.14% of the cleared RICSA volume, while only 10.96% of RICSA was found in the blood during the 8-h experiment. The amount of RICSA remaining in the brain when the animal was killed equaled 71.2 +/- 15.9% (mean +/- SD) of the RICSA infused. We conclude that vascular clearance during the acute stage of resolution is minimal and that clearance of RICSA occurs predominantly via the CSF pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067404     DOI: 10.1152/ajpheart.1994.267.2.H514

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Pseudo-subarachnoid hemorrhage: a potential imaging pitfall associated with diffuse cerebral edema.

Authors:  Curtis A Given; Jonathan H Burdette; Allen D Elster; Daniel W Williams
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

Review 2.  Mechanisms of astrocyte-mediated cerebral edema.

Authors:  Jesse A Stokum; David B Kurland; Volodymyr Gerzanich; J Marc Simard
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

3.  Cerebrospinal fluid drainage and cranial decompression prolong survival in rats with fulminant hepatic failure.

Authors:  Satoshi Yamamoto; Jeffery L Steers; Robert E Wharen; Christopher B Eckman; Justin H Nguyen
Journal:  Transpl Int       Date:  2006-08       Impact factor: 3.782

4.  Perspectives on neonatal hypoxia/ischemia-induced edema formation.

Authors:  Diana Carolina Ferrari; Olivera Nesic; Jose Regino Perez-Polo
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

5.  Increased brain edema in aqp4-null mice in an experimental model of subarachnoid hemorrhage.

Authors:  M J Tait; S Saadoun; B A Bell; A S Verkman; M C Papadopoulos
Journal:  Neuroscience       Date:  2010-02-01       Impact factor: 3.590

6.  Acute and chronic changes in aquaporin 4 expression after spinal cord injury.

Authors:  O Nesic; J Lee; Z Ye; G C Unabia; D Rafati; C E Hulsebosch; J R Perez-Polo
Journal:  Neuroscience       Date:  2006-10-30       Impact factor: 3.590

7.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

8.  Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption?

Authors:  Lena Koh; Andrei Zakharov; Miles Johnston
Journal:  Cerebrospinal Fluid Res       Date:  2005-09-20

9.  The effect of halothane and pentobarbital sodium on brain ependymal cilia.

Authors:  Chris O'Callaghan; Kulvinder Sikand
Journal:  Cilia       Date:  2012-07-06

Review 10.  Aquaporin-4: A Potential Therapeutic Target for Cerebral Edema.

Authors:  Guanghui Tang; Guo-Yuan Yang
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.